Experimental Study of Quality of Life in Patients With Endometriosis and Pelvic Pain Treated With Doliral Dietary Supplementation Versus Placebo

What this Trial Is About

This research aims to evaluate whether the food supplement Doliral can improve quality of life and reduce pelvic pain in women diagnosed with endometriosis. The study compares Doliral to a placebo over a period of 12 weeks, focusing on women of reproductive age with specific stages of endometriosis and pelvic pain. The trial is designed to assess changes in quality of life and pain intensity, with patients grouped based on hormonal therapy use. Participants are randomly assigned to one of two groups one receiving Doliral and the other a placebo. Each participant takes one buccal tablet daily from the baseline visit to the final visit, spanning 12 weeks. The study includes six visits one selection visit, a baseline visit, and four follow-up visits to monitor progress and collect data. During the study, patients complete a daily symptom diary and record their use of pain and anti-inflammatory medications. At each visit, pain intensity is assessed using the Visual Analog Scale VAS for different types of endometriosis pain. Several quality of life questionnaires are also completed. Researchers will monitor changes in pain, quality of life, medication use, and the frequency of clinically relevant episodes, ensuring close follow-up over the study period.

Impact of Food Supplementation on Quality of Life in Patients With Endometriosis and Pelvic Pain.